http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101810395-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2525-205 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-112 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate | 2015-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101810395-B1 |
| titleOfInvention | Diagnostic biomarker for Moyamoya disease and use thereof |
| abstract | The present invention discloses RALDH2 biomarkers used for the diagnosis of moyamoya disease and uses thereof. The biomarker according to the present invention can be used not only for early diagnosis of moyamoya disease but also for time and economical efficiency compared to conventional brain magnetic resonance imaging, brain scan using brain blood flow test, and cerebral angiography And can be used alone or in combination with existing methods. Also, RALDH2 according to the present invention can be effectively used as a target of development of a therapeutic agent for moyamoya disease, and as a composition for treatment using the protein, an activator thereof or an expression regulating agent. |
| priorityDate | 2015-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1263.